Transitional Housing and HIV Health
Part of paid clinical trials in Philadelphia, Pennsylvania.
- Sponsor
- University of Pennsylvania
- Study ID
- NCT06829394
- Status
- Recruiting
Conditions
- HIV
- HIV Antiretroviral Therapy (ART) Adherence
- Housing Instability
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Program Assignment — OTHERThe intervention group will include People living with HIV who were assigned to the Arms Around You Program in the lottery.
Study Details
The goal of this pilot study is to evaluate the implementation and outcomes of the Arms Around You (AAY) program, a supportive housing initiative launched by the Philadelphia Department of Public Health (PDPH) in 2024. The program aims to address housing instability among people with HIV (PWH) using a Housing First model. The main questions it seeks to answer are: 1. How does AAY affect HIV-related outcomes, particularly viral suppression and antiretroviral therapy (ART) adherence? 2. What are the program's effects on economic, psychological, and secondary health outcomes? 3. How feasible, acceptable, and scalable is the program for broader implementation? Participants will be assigned to immediate program access or a waitlist using a random lottery system, creating treatment and control groups, respectively. Surveys and health data will be collected at baseline and over 36 months to assess changes in outcomes such as viral suppression, housing security, mental health, and financial well-being. Qualitative interviews with participants and stakeholders will complement quantitative findings to explore mechanisms of change and guide program optimization.
Key Dates
- Start date
- Feb 25, 2025
- Status verified
- Mar 2026
- Primary completion
- Jan 31, 2028
- Completion
- Aug 31, 2028
Study Design
- Enrollment
- 200 participants (estimated)
Arms
- Arm: Arms Around You Program WaitlistThese are individuals that are part of the lottery but not yet assigned to the program.
- Arm: Arms Around You Program RecipientsThese are individuals that were part of the lottery AND assigned to the program
Primary Outcome Measure
HIV viral suppression - defined as HIV RNA < 200 copies/mL [ Time Frame: From lottery to 12 months after the lottery ]
Central Contacts
- Aaron Richterman, MD, MPH267-441-7915
- Eva Fabian, MPH760-791-2633
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | - |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 |
Find similar trials in Philadelphia, PA
Related Studies
- Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)Recruiting · Johns Hopkins University · Birmingham, Alabama
- The Collaborative Care PrTNER StudyRecruiting · Children's Hospital of Philadelphia · Baltimore, Maryland
- Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIVPHASE2 · Recruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Birmingham, Alabama
- A Study of VRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal Antibodies Given Intravenously in Adult Participants Without HIVPHASE2 · Recruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Birmingham, Alabama